TrialPanorama/TrialPanorama-database huggingface dataset:
Study 34315519 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study 34315767 — Predictive Biomarker (PRD): DLL4 mRNA
Genes: DLL4; UNQ1895/PRO4341
Study 34315767 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34315821 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34320287 — Pharmacodynamic Biomarker (PDY): Survival motor neuron protein
Genes: SMN1; SMN; SMNT;; SMN2; SMNC
Study 34320342 — Predictive Biomarker (PRD): DUSP4 mRNA
Genes: DUSP4; MKP2; VH2
Study 34320785 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34320785 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 34320980 — Predictive Biomarker (PRD): Vitamin D-binding protein
Genes: GC
Study 34321095 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study 34321407 — Predictive Biomarker (PRD): ARC mRNA
Genes: ARC; KIAA0278
Study 34321583 — Monitoring Biomarker (MOI): Carcinoembryonic antigen CEA
Genes: CEACAM5; CEA
Study 34321836 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34321921 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 34321921 — Safety Biomarker (SAF): Hyaluronic acid
Study 34322775 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34322775 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34323296 — Predictive Biomarker (PRD): SI mRNA
Genes: SI
Study 34323296 — Surrogate Endpoint (SUR): Serum creatinine
Study 34323296 — Safety Biomarker (SAF): Cystatin C
Genes: CST3
Study 34323406 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34323413 — Predictive Biomarker (PRD): MMRN1 mRNA
Genes: MMRN1; ECM; EMILIN4; GPIA*; MMRN
Study 34323957 — Predictive Biomarker (PRD): FCGR2A mRNA
Genes: FCGR2A; CD32; FCG2; FCGR2A1; IGFR2
Study 34323957 — Predictive Biomarker (PRD): FCGR3A mRNA
Genes: FCGR3A; CD16A; FCG3; FCGR3; IGFR3
Study 34323957 — Predictive Biomarker (PRD): FCGR2B mRNA
Genes: FCGR2B; CD32; FCG2; IGFR2
Study 34323958 — Predictive Biomarker (PRD): FCGR2B mRNA
Genes: FCGR2B; CD32; FCG2; IGFR2
Study 34324392 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study 34324451 — Predictive Biomarker (PRD): GREM1 mRNA
Genes: GREM1; CKTSF1B1; DAND2; DRM; PIG2
Study 34324500 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34324524 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34325726 — Safety Biomarker (SAF): C-C motif chemokine 19
Genes: CCL19; ELC; MIP3B; SCYA19
Study 34325726 — Predictive Biomarker (PRD): GPC3 mRNA
Genes: GPC3; OCI5
Study 34325726 — Predictive Biomarker (PRD): MSLN mRNA
Genes: MSLN; MPF
Study 34326188 — Predictive Biomarker (PRD): COL4A3 mRNA
Genes: COL4A3
Study 34326920 — Safety Biomarker (SAF): Myeloperoxidase
Genes: MPO
Study 34326920 — Pharmacodynamic Biomarker (PDY): Superoxide dismutase Cu-Zn
Genes: SOD1
Study 34327207 — Surrogate Endpoint (SUR): Blood pressure
Study 34327604 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34327604 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34328338 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34328563 — Safety Biomarker (SAF): SLC6A3
Genes: DAT
Study 34329317 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34329401 — Predictive Biomarker (PRD): Activated leukocyte cell adhesionmolecule
Genes: ALCAM; MEMD
Study 34329401 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): Matrix metalloproteinase 3
Genes: MMP3; STMY1
Study 34329576 — Predictive Biomarker (PRD): Apoptosis regulator Bcl-2
Genes: BCL2
Study 34329576 — Predictive Biomarker (PRD): FLT3 mRNA
Genes: FLT3; CD135; FLK2; STK1
Study 34330322 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-C motif chemokine 2
Genes: CCL2; MCP1; SCYA2
Study 34330322 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34330417 — Predictive Biomarker (PRD): SAGE1 mRNA
Genes: SAGE1; SAGE
Study 34330715 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34330792 — Predictive Biomarker (PRD): ID1 mRNA
Genes: ID1; BHLHB24; ID
Study 34330970 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 34330970 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34331051 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34331258 — Surrogate Endpoint (SUR): Blood pressure
Study 34331265 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 34331515 — Predictive Biomarker (PRD): MYCN mRNA
Genes: MYCN; BHLHE37; NMYC
Study 34331515 — Predictive Biomarker (PRD): VIP mRNA
Genes: VIP
Study 34331588 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CAT mRNA
Genes: CAT
Study 34332113 — Predictive Biomarker (PRD): COL1A1 mRNA
Genes: COL1A1
Study 34332113 — Predictive Biomarker (PRD): COL3A1 mRNA
Genes: COL3A1
Study 34332113 — Predictive Biomarker (PRD): COL8A2 mRNA
Genes: COL8A2
Study 34332113 — Predictive Biomarker (PRD): TNC mRNA
Genes: TNC; HXB
Study 34332113 — Predictive Biomarker (PRD): BGN mRNA
Genes: BGN; SLRR1A
Study 34332113 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Endothelin-1
Genes: EDN1
Study 34332113 — Predictive Biomarker (PRD): SCN2B mRNA
Genes: SCN2B; UNQ326/PRO386
Study 34332113 — Predictive Biomarker (PRD): KCNJ2 mRNA
Genes: KCNJ2; IRK1
Study 34332558 — Predictive Biomarker (PRD): ACD mRNA
Genes: ACD; PIP1; PTOP; TINT1; TPP1
Study 34332614 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34333554 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34334250 — Predictive Biomarker (PRD): TNFR1B
Genes: TNFRSF1B; TNFBR; TNFR80; TNF-R75; TNF-R-II; p75; CD120b
Study 34335289 — Surrogate Endpoint (SUR): Blood pressure
Study 34335465 — Surrogate Endpoint (SUR): Blood pressure
Study 34337278 — Predictive Biomarker (PRD): GCG mRNA
Genes: GCG
Study 34337278 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Free fatty acids
Study 34337278 — Pharmacodynamic Biomarker (PDY): Gastric inhibitory polypeptide
Genes: GIP
Study 34337481 — Predictive Biomarker (PRD): NPEPPS mRNA
Genes: NPEPPS; PSA
Study 34338965 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34338965 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34338965 — Predictive Biomarker (PRD): Hormone receptor
Study 34339292 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34341142 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34341335 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34341335 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34342768 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34343142 — Surrogate Endpoint (SUR): Blood pressure
Study 34343354 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34343443 — Predictive Biomarker (PRD): CCR5 mRNA
Genes: CCR5; CMKBR5
Study 34347542 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34347542 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34347859 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34348230 — Surrogate Endpoint (SUR): Blood pressure
Study 34348472 — Predictive Biomarker (PRD): CLNK mRNA
Genes: CLNK; MIST
Study 34348472 — Predictive Biomarker (PRD): DHPS mRNA
Genes: DHPS; DS
Study 34348965 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34348965 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34348965 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34348965 — Surrogate Endpoint (SUR): Blood pressure
Study 34349180 — Predictive Biomarker (PRD): MCTS1 mRNA
Genes: MCTS1; MCT1
Study 34350827 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34351679 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34352834 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34353317 — Predictive Biomarker (PRD): KL mRNA
Genes: KL
Study 34353802 — Monitoring Biomarker (MOI): Procalcitonin
Study 34353848 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34354225 — Predictive Biomarker (PRD): DLL3 mRNA
Genes: DLL3
Study 34354920 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34355354 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study 34355741 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Lactate dehydrogenase
Study 34358399 — Predictive Biomarker (PRD): GFAP mRNA
Genes: GFAP
Study 34358484 — Predictive Biomarker (PRD): FGFR2 mRNA
Genes: FGFR2; BEK; KGFR; KSAM
Study 34358835 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study 34359048 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34359048 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34360198 — Surrogate Endpoint (SUR): Blood pressure
Study 34362196 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34362217 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34362310 — Predictive Biomarker (PRD): MMD mRNA
Genes: MMD; PAQR11
Study 34362494 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34362494 — Predictive Biomarker (PRD); Safety Biomarker (SAF): CARTPT mRNA
Genes: CARTPT; CART
Study 34363189 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34363189 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34363189 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 34363189 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34365516 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study 34365516 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Cellular tumor antigen p53
Genes: TP53; P53
Study 34367149 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34367728 — Safety Biomarker (SAF): Interleukin 1
Study 34367728 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34368249 — Predictive Biomarker (PRD): IL1RL1 mRNA
Genes: IL1RL1; DER4; ST2; T1
Study 34369165 — Predictive Biomarker (PRD): PCSK9 mRNA
Genes: PCSK9; NARC1; PSEC0052
Study 34369165 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34369187 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34369187 — Pharmacodynamic Biomarker (PDY): High density lipoprotein cholesterol
Study 34369198 — Surrogate Endpoint (SUR): Blood pressure
Study 34369385 — Predictive Biomarker (PRD): Thymidylate synthase 
Genes: TYMS; TS; OK/SW-cl.29
Study 34369416 — Predictive Biomarker (PRD): COCH mRNA
Genes: COCH; COCH5B2; UNQ257/PRO294
Study 34369417 — Predictive Biomarker (PRD): COCH mRNA
Genes: COCH; COCH5B2; UNQ257/PRO294
Study 34369424 — Predictive Biomarker (PRD): CYP2B6 mRNA
Genes: CYP2B6
Study 34369424 — Predictive Biomarker (PRD): SLC38A1 mRNA
Genes: SLC38A1; ATA1; NAT2; SAT1; SNAT1
Study 34371380 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34372979 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34373315 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study 34374848 — Surrogate Endpoint (SUR): Serum calcium
Study 34375311 — Predictive Biomarker (PRD): ARID1B mRNA
Genes: ARID1B; BAF250B; DAN15; KIAA1235; OSA2
Study 34375311 — Predictive Biomarker (PRD): Microsatellite instability
Study 34375314 — Predictive Biomarker (PRD): HHIP mRNA
Genes: HHIP; HIP; UNQ5825/PRO19644
Study 34375315 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34375986 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34376552 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34376552 — Predictive Biomarker (PRD): Microsatellite instability
Study 34376578 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34376579 — Predictive Biomarker (PRD): CD38 mRNA
Genes: CD38
Study 34376577 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34377989 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study 34380543 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34380625 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study 34380662 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study 34380662 — Predictive Biomarker (PRD): Hormone receptor
Study 34380663 — Predictive Biomarker (PRD): Programmed cell death 1 ligand 1
Genes: CD274; B7H1; PDCD1L1; PDCD1LG1; PDL1
Study 34380725 — Predictive Biomarker (PRD): ACR mRNA
Genes: ACR; ACRS
Study 34381030 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34381802 — Surrogate Endpoint (SUR): Blood pressure
Study 34382365 — Safety Biomarker (SAF): Argininosuccinate synthase
Genes: ASS1; ASS
Study 34382365 — Predictive Biomarker (PRD); Safety Biomarker (SAF): TP53
Genes: p53; LFS1
Study 34382365 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34382603 — Predictive Biomarker (PRD): LBP mRNA
Genes: LBP
Study 34382998 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34382998 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34382998 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study 34382998 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34382998 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study 34382998 — Predictive Biomarker (PRD): Microsatellite instability
Study 34383157 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34383774 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 34383902 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34384145 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34384145 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34384384 — Predictive Biomarker (PRD): LAMA2 mRNA
Genes: LAMA2; LAMM
Study 34384384 — Predictive Biomarker (PRD): SELENON mRNA
Genes: SELENON; SELN; SEPN1
Study 34384460 — Monitoring Biomarker (MOI): Urokinase plasminogen activator surface receptor
Genes: PLAUR; MO3; UPAR
Study 34384490 — Predictive Biomarker (PRD): TES mRNA
Genes: TES
Study 34384490 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study 34384695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34384709 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34384709 — Predictive Biomarker (PRD): MS4A4A mRNA
Genes: MS4A4A; 4SPAN1; CD20L1; MS4A4; HDCME31P
Study 34385343 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34385584 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study 34385584 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34385584 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34385584 — Predictive Biomarker (PRD): DNER mRNA
Genes: DNER; BET; UNQ262/PRO299
Study 34385584 — Predictive Biomarker (PRD): CDK6 mRNA
Genes: CDK6; CDKN6
Study 34385584 — Predictive Biomarker (PRD): CCND1 mRNA
Genes: CCND1; BCL1; PRAD1
Study 34385584 — Predictive Biomarker (PRD): Hormone receptor
Study 34385584 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34385708 — Predictive Biomarker (PRD): Tumor-infiltrating lymphocyte
Study 34385708 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34386974 — Predictive Biomarker (PRD): TPO mRNA
Genes: TPO
Study 34387310 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study 34387648 — Predictive Biomarker (PRD): Leukocyte surface antigen Leu-16
Genes: MS4A1; CD20
Study 34388205 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34388324 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study 34388324 — Predictive Biomarker (PRD): WAP four-disulfide core domain protein 2
Genes: WFDC2; HE4; WAP5
Study 34388386 — Predictive Biomarker (PRD): BRCA1 mRNA
Genes: BRCA1; RNF53
Study 34388386 — Predictive Biomarker (PRD): BRCA2 mRNA
Genes: BRCA2; FACD; FANCD1
Study 34388386 — Predictive Biomarker (PRD): CHEK2 mRNA
Genes: CHEK2; CDS1; CHK2; RAD53
Study 34388386 — Predictive Biomarker (PRD): FANCA mRNA
Genes: FANCA; FAA; FACA; FANCH
Study 34388386 — Predictive Biomarker (PRD): MLH1 mRNA
Genes: MLH1; COCA2
Study 34388386 — Predictive Biomarker (PRD): NBN mRNA
Genes: NBN; NBS; NBS1; P95
Study 34388386 — Predictive Biomarker (PRD): PALB2 mRNA
Genes: PALB2; FANCN
Study 34388386 — Predictive Biomarker (PRD): RAD51C mRNA
Genes: RAD51C; RAD51L2
Study 34389003 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study 34389003 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34389161 — Safety Biomarker (SAF): Glucose-6-phosphate dehydrogenase
Genes: G6PD
Study 34389234 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study 34389237 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34389568 — Predictive Biomarker (PRD): PPP1R12A mRNA
Genes: PPP1R12A; MBS; MYPT1
Study 34389610 — Safety Biomarker (SAF): Transforming growth factor beta 1
Genes: TGFB1; TGFB
Study 34389618 — Predictive Biomarker (PRD): TNFRSF18 mRNA
Genes: TNFRSF18; AITR; GITR; UNQ319/PRO364
Study 34389618 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34389694 — Predictive Biomarker (PRD): XIAP mRNA
Genes: XIAP; API3; BIRC4; IAP3
Study 34389923 — Surrogate Endpoint (SUR): Blood pressure
Study 34390050 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study 34391399 — Predictive Biomarker (PRD): TGIF1 mRNA
Genes: TGIF1; TGIF
Study 34391399 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study 34391922 — Predictive Biomarker (PRD): AFP mRNA
Genes: AFP; HPAFP
Study 34391922 — Predictive Biomarker (PRD): HOXA1 mRNA
Genes: HOXA1; HOX1F
Study 34391922 — Predictive Biomarker (PRD): TSPYL5 mRNA
Genes: TSPYL5; KIAA1750
Study 34391922 — Predictive Biomarker (PRD): B3GALT6 mRNA
Genes: B3GALT6
Study 34392187 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study 34392453 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study 34395277 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study 34396157 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34396157 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study 34396210 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34397100 — Surrogate Endpoint (SUR): Blood pressure
Study 34397707 — Surrogate Endpoint (SUR): Blood pressure
Study 34397707 — Pharmacodynamic Biomarker (PDY): Low-density lipoprotein
Study 34397713 — Predictive Biomarker (PRD): JAK1 mRNA
Genes: JAK1; JAK1A; JAK1B
Study 34397713 — Predictive Biomarker (PRD): JAK2 mRNA
Genes: JAK2
Study 34398238 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study 34399717 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study 34399717 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study 34399717 — Safety Biomarker (SAF): IL-6 and IL-10
Study 34399830 — Predictive Biomarker (PRD): CD14 mRNA
Genes: CD14
Study 34399830 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34399830 — Safety Biomarker (SAF): IL-6 and IL-10
Study 34400140 — Safety Biomarker (SAF): B-type natriuretic peptide
Genes: NPPB
Study 34400337 — Predictive Biomarker (PRD); Safety Biomarker (SAF): HLA-B
Genes: AS
Study 34400362 — Surrogate Endpoint (SUR): Blood pressure
Study 34401374 — Predictive Biomarker (PRD): BCAR1 mRNA
Genes: BCAR1; CAS; CASS1; CRKAS
Study 34401690 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study 34401861 — Surrogate Endpoint (SUR): Blood pressure
Study 34401888 — Surrogate Endpoint (SUR): Neutralizing antibody
Study 34402466 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study 34402876 — Predictive Biomarker (PRD): CFH mRNA
Genes: CFH; HF; HF1; HF2
Study 34403803 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study 34404458 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study 34404463 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study 34407735 — Predictive Biomarker (PRD): CD22 mRNA
Genes: CD22; SIGLEC2
Study 34407844 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study 34407844 — Predictive Biomarker (PRD): PAM mRNA
Genes: PAM
Study 34407844 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study 34407844 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study 34407844 — Predictive Biomarker (PRD): AKT2 mRNA
Genes: AKT2
Study 34407972 — Predictive Biomarker (PRD): CEBPA mRNA
Genes: CEBPA; CEBP
Study 34408049 — Monitoring Biomarker (MOI): HBV DNA
Study 34408662 — Predictive Biomarker (PRD): PGC mRNA
Genes: PGC
Study 34409288 — Safety Biomarker (SAF): Interleukin 2
Genes: IL2
Study 34409513 — Surrogate Endpoint (SUR): Blood pressure
Study 34409593 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study 34409776 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF